MiMedx is headquartered in Marietta, Georgia.
MiMedx disclosed revenue of 349M USD for 2024 and 321M USD for 2023.
MiMedx has 837 employees.
MiMedx is a life science company.
MiMedx was founded in 2006.
1775 West Oak Commons Court, NE,
Marietta, Georgia
30062
United States,
(770) 651-9100
www.mimedx.com
MiMedx is an advanced wound care and an emerging therapeutic biologics company developing and distributing human placental tissue allografts with patent-protected processes for multiple sectors of healthcare. The Company processes the human placental tissue utilizing its proprietary PURION process methodology, among other processes, to produce allografts by employing aseptic processing techniques in addition to terminal sterilization. MiMedx was formed in 2006 and is based in Marietta, Georgia.
| Year | ≤ '20 | '21 | '22 | '23 | '24 | '25 | T | |
|---|---|---|---|---|---|---|---|---|
| Buy (0.0/yr) | # | 2 | - | - | - | - | - | 2 |
| Sell (0.0/yr) | # | - | - | - | - | - | - | 0 |
| 2 | ||||||||
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
